"Cholesterol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.
| Descriptor ID |
D002784
|
| MeSH Number(s) |
D04.210.500.247.222.284 D04.210.500.247.808.197 D10.570.938.208
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cholesterol".
Below are MeSH descriptors whose meaning is more specific than "Cholesterol".
This graph shows the total number of publications written about "Cholesterol" by people in this website by year, and whether "Cholesterol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 3 | 7 |
| 1996 | 2 | 3 | 5 |
| 1997 | 1 | 7 | 8 |
| 1998 | 1 | 3 | 4 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 6 | 7 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2003 | 2 | 10 | 12 |
| 2004 | 3 | 2 | 5 |
| 2005 | 3 | 3 | 6 |
| 2006 | 0 | 10 | 10 |
| 2007 | 1 | 3 | 4 |
| 2008 | 5 | 7 | 12 |
| 2009 | 4 | 3 | 7 |
| 2010 | 3 | 8 | 11 |
| 2011 | 5 | 3 | 8 |
| 2012 | 3 | 7 | 10 |
| 2013 | 4 | 8 | 12 |
| 2014 | 2 | 1 | 3 |
| 2015 | 4 | 6 | 10 |
| 2016 | 3 | 10 | 13 |
| 2017 | 4 | 7 | 11 |
| 2018 | 4 | 4 | 8 |
| 2019 | 3 | 6 | 9 |
| 2020 | 1 | 3 | 4 |
| 2022 | 2 | 3 | 5 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholesterol" by people in Profiles.
-
Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program. Popul Health Manag. 2023 02; 26(1):72-82.
-
Lipoprotein(a) and LDL-C: The Relevance of Equivalence. J Am Coll Cardiol. 2022 11 22; 80(21):2011-2013.
-
Reducing Disparities in Cholesterol Control. JAMA. 2022 08 23; 328(8):714-716.
-
NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A/MEK/ERK/c-Jun/ABCA1 pathway mediated membrane fluidity. Cancer Lett. 2022 10 28; 547:215884.
-
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation. 2022 Aug 30; 146(9):657-672.
-
Polyploid giant cancer cells are dependent on cholesterol for progeny formation through amitotic division. Sci Rep. 2022 05 27; 12(1):8971.
-
Comorbidities associated with different levels of total cholesterol in male and female acute ischemic stroke patients. Medicine (Baltimore). 2020 Dec 24; 99(52):e23870.
-
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial. Eur Heart J. 2020 11 21; 41(44):4245-4255.
-
Sociodemographic Determinants of Life's Simple 7: Implications for Achieving Cardiovascular Health and Health Equity Goals. Ethn Dis. 2020; 30(4):637-650.
-
Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2? Am J Physiol Endocrinol Metab. 2020 07 01; 319(1):E197-E202.